<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commenti a: Farmaceutica, Rosati (Gsk): &#8220;Prodotto in Italia il primo Adc per mieloma multiplo&#8221; All&#8217;evento Innovaction, ‘con belantamab mafodotin terapia mirata’	</title>
	<atom:link href="https://www.lafrecciaweb.it/2026/04/09/farmaceutica-rosati-gsk-prodotto-in-italia-il-primo-adc-per-mieloma-multiplo-allevento-innovaction-con-belantamab-mafodotin-terapia-mirata/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.lafrecciaweb.it/2026/04/09/farmaceutica-rosati-gsk-prodotto-in-italia-il-primo-adc-per-mieloma-multiplo-allevento-innovaction-con-belantamab-mafodotin-terapia-mirata/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=farmaceutica-rosati-gsk-prodotto-in-italia-il-primo-adc-per-mieloma-multiplo-allevento-innovaction-con-belantamab-mafodotin-terapia-mirata</link>
	<description>la velocità dell&#039;informazione</description>
	<lastBuildDate>Thu, 09 Apr 2026 12:18:00 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
